The treatment of opioid withdrawal is an important area of clinical concern when treating
patients with chronic, non-cancer pain, patients with active opioid use disorder, and patients …

Methadone at tapered doses for the management of opioid withdrawal - Amato, L - 2003 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Opioid use disorder continues to be a significant source of morbidity and mortality in the
USA and the world. Pharmacologic treatment with methadone and buprenorphine has been …

Introduction: Alcohol misuse is the fifth leading risk factor for premature death and disability
worldwide. Fewer than 10% of afflicted Americans receive pharmacological treatment for …

Historically, most pharmacological approaches to the treatment of addictive disorders have
utilized either substitution-based methods (ie, nicotine replacement or opioid maintenance) …

Objective: Gabapentin (GBP) is an anticonvulsant medication that is also used to treat
restless legs syndrome (RLS) and posttherapeutic neuralgia. GBP is commonly prescribed …

Objective: Gabapentin is commonly used off-label in the treatment of psychiatric disorders
with success, failure, and controversy. A systematic review of the literature was performed to …

The clinical interface between psychiatry and neurology is epilepsy; the pharmacological
expression of this interface is antiepileptic drugs (AEDs), as they are used to treat both …

Drug addiction represents a major social problem where addicts and alcoholics continue to
seek and take drugs despite adverse social, personal, emotional, and legal consequences …

Background Previous studies demonstrate that the reformulation of OxyContin in the US in
2010 induced substitution to illicit opioids, causing illicit opioid markets to grow …